devoted to determining and implementing the best ways
to prevent, diagnose and treat diseases in children
in an independent global collaboration that seeks to standardize
best practices across disease areas and populations
such as flexibility, commitment and transparency
to generate the scientific data necessary to market drugs
at doses that are safe and effective for children
so as to harness the body's response
to HIV and antiretrovirals
to ensure effective treatments are available
for common infections for generations to come
to make powerful informed decisions about their health
and healthcare and improve the quality of their lives
The Spanish language version of our online course “PentaTr@ining: HIV and other Congenital Infections” kicks off today! We look forward to welcoming over 100 participants for this year’s edition of our newly upgraded online training course. Unique in its design and delivery, ‘PentaTr@ining’ is an innovative training platform which continues to develop and evolve in…READ MORE
Project New Generation (PNG+) are a group of young people living with HIV who serve as the voice of the youth involved in the REACH study. Made up of two groups, one based in St. Petersburg and the other in Irkutsk, and supported by local psychologists, this group of 20 bring to the forefront, issues…READ MORE
The conect4children (c4c) project has recently released their third podcast, The best kept secret of science communication. This podcast, with speakers Claudio Fracasso and Lindesyt Hunter, the leads of the c4c communication, dissemination, exploitation and impact assessment working group, focuses on the importance of science communication, how it should be done to be effective and how…READ MORE
The second edition of Pediatric Vaccines and Vaccinations: A European Textbook, is now available for purchase! Included in this second edition is a new chapter covering COVID-19 vaccines. Written by leading European experts, the textbook serves as a guide on vaccines and vaccinations in infants, children and adolescents. It aims to provide essential information on the current…READ MORE
Through independent research into child health operating on global scale, Penta is one of the most prominent scientific organizations dedicated to children’s health.
We are a non-profit Foundation with a remarkable expertise in coordinating projects, optimizing their financial and administrative management, disseminating scientific results and delivering training programs. The Foundation is sponsor of clinical trials according to the GCP guidelines and new relevant European Directives. We have recently entered into a number of framework collaboration agreements with world-leading paediatric research institutions.
We are an operational network, that brings together key stakeholders in paediatric infectious disease, including researchers, clinicians, regulatory bodies, the pharmaceutical industry and patients and their families, to plan and carry out high quality clinical research and training.
The network was established in 1991 as a collaboration between paediatric HIV centres in Europe. The primary aim of the network was to undertake independent clinical trials to address questions about antiretroviral therapies in HIV infected children, where answers could not be extrapolated from trials in adults. In 2011 the Penta network officially evolved into PENTA-ID (Infectious Diseases), extending its research to other paediatric infectious diseases. As such, we have been involved in several non HIV-related projects: where the main research focus is on adults, Penta represents a gateway for paediatric expertise thanks to its very well established network of paediatric hospitals. The Network now spans over 100 clinical sites in 28 countries, providing the access to paediatric patients necessary to perform clinical research.
In addition to coordinating and participating in trials and cohort studies, the Network develops treatment guidelines and training programmes for health care professionals thus contributing to European and global efforts to improve research infrastructure and harmonize and streamline research methods.
Currently the Penta Foundation and its network are involved in research projects in various developing countries that operate along 3 main lines of intervention: HIV and other viruses, Severe infections and Antimicrobial resistance, other infections in women and children.
In 2016 a spin off company (Penta ID Innovation) was set up by the Foundation in order to provide services to companies and invest directly in specific projects.
We look forward to building on our existing partnerships and seeking out potential new collaborations. Together, we are continually striving to improve the quality of life of children and their families.
[et_bloom_inline optin_id=”optin_2″]
The Penta ID Network continues to grow, bringing together patients and their care-givers worldwide to address a wide range of healthcare issues.
